Zoetis Inc. IPO Research Information

Zoetis Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Zoetis Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Zoetis Inc.	ZTS - NYSE	$22.00-$25.00	$26.00	$31.50	86.1 million	2/1/2013
Underwriter(s): J.P. Morgan, BofA Merrill Lynch, Morgan Stanley
Co-Manager(s): Barclays, Citigroup, Credit Suisse, Deutsche Bank Securities, Goldman Sachs, Guggenheim Securities, Jefferies, BNP Paribas, HSBC, Loop Capital Markets, RBC Capital Markets, Williams Capital Group, UBS Investment Bank, Lebenthal, Piper Jaffray
Industry: Health Care
Filing(s): Filed 2012-08-10

Zoetis Inc. Quote & Chart - Click for current quote - ZTS

About Zoetis Inc. (adapted from Zoetis Inc. prospectus):
They are a global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ZTS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.